Integral Diagnostics

AI And Teleradiology Expansion Will Drive Long Term Diagnostic Imaging Leadership

AnalystHighTarget

Not Invested

Community Contributor

Published

18 Dec 25

Views

n/a

AnalystHighTarget's Fair Value

n/a

-19.7%

-1.6%

-19.7%

-1.6%

You can edit this narrative until Dec 19 11:05 AM. Then, changes will post as Updates.

Author's Valuation

AU$439.8% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

AU$4

39.8% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

9.74%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.70%

Calculation

AU$86.28m

Earnings '28

21.06x

PE Ratio '28

AU$1.82b

Market Cap '28

AU$1.82b

Market Cap '28

374.05m

No. shares '28

AU$4.86

Share Price '28

AU$4.86 Share Price '28

Discounted to 2025 @ 6.68% p.a.

AU$4.00

Fair Value '25